Our previous studies demonstrated that serum CCL17 levels are associated with coronary artery disease and atherosclerosis severity, independently of traditional cardiovascular risk factors (Ye et al., 2017; Ye et al., 2015; Ye et al., 2014). Here, CCL17 is linked to coronary artery disorder.